Globe Newswire (Wed, 9-Sep 9:15 AM ET)
Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
Globe Newswire (Tue, 18-Aug 4:15 PM ET)
Silo Pharma Granted European Patent Covering Novel PTSD Therapy
Globe Newswire (Mon, 10-Aug 8:15 AM ET)
Globe Newswire (Thu, 6-Aug 8:50 AM ET)
Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program
Globe Newswire (Tue, 21-Jul 8:55 AM ET)
Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform
Globe Newswire (Tue, 14-Jul 8:55 AM ET)
Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Globe Newswire (Fri, 10-Jul 8:00 AM ET)
Market Chameleon (Tue, 7-Jul 4:33 AM ET)
Globe Newswire (Tue, 7-Jul 8:11 AM ET)
Globe Newswire (Mon, 29-Jun 4:15 PM ET)
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
Silo Pharma trades on the NASDAQ stock market under the symbol SILO.
As of September 11, 2026, SILO stock price climbed to $2.14 with 24,863 million shares trading.
SILO has a beta of -2.66, meaning it tends to be less sensitive to market movements. SILO has a correlation of 0.01 to the broad based SPY ETF.
SILO has a market cap of $3.75 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, SILO traded as high as $7.95 and as low as $.22.
The top ETF exchange traded funds that SILO belongs to (by Net Assets): PSIL, VXF.
SILO has outperformed the market in the last year with a return of +234.7%, while the SPY ETF gained +18.5%. However, in the most recent history, SILO shares have underperformed the stock market with its stock returning -66.6% in the last 3 month period and -15.7% for the last 2 week period, while SPY has returned +5.8% and -0.7%, respectively.
SILO support price is $1.95 and resistance is $2.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SILO shares will trade within this expected range on the day.
